Percutaneous Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: Managing the Risk of Procedure-related AV Conduction Disturbances
Overview
Authors
Affiliations
Aim: To provide tools for predicting the course of AV conduction disturbances after ethanol-induced septal ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM).
Methods And Results: Based on a scoring system developed 1996-1998 and including parameters from baseline ECG, heart rate profile, severity of outflow obstruction (LVOTO), peri-interventional enzyme kinetics, and peri-interventional conduction problems, the risk of permanent AV block following PTSMA was assessed in 155 consecutive HOCM patients (pts.; mean age: 53+/-13 years) between 1999 and 2004. During PTSMA with 2.1+/-0.5 ml of ethanol, transient complete AV block occurred in 71 pts. (46%). Pts. were grouped into a low, intermediate, and high risk group for permanent conduction damage, and treated accordingly (early discharge from monitoring, prolonged monitoring, early DDD-PM implantation). Permanent pacing was necessary in 11 cases (7%), 0/116 of these (0%) in the low, 4/31 (13%) in the intermediate, and 7/8 (87%) in the high-risk group. While a new right bundle branch block was the most frequent ECG finding after PTSMA, a left bundle branch block at baseline was associated with 4 of the 11 DDD-PM implantations (p<0.0001). In-hospital mortality was 0%, short-term (3-months) follow up was complete. During follow-up, AV conduction recovered in 4 pts. (46%) with a DDD-PM. New onset AV blocks did not occur. Significant improvement of symptoms was reported by 141 pts. (91%).
Conclusions: Catheter-based septal ablation is an effective non-surgical technique for reducing symptoms and outflow gradients in HOCM. The proposed scoring system appears to reliably discriminate pts. with a high risk for permanent PM dependency from those with stable AV conduction after PTSMA. Pts. with left bundle branch block at baseline should undergo DDD-PM implantation prior to ablation.
Bansal P, Lodhi H, Mathews A, Desai A, Morcos R, Maini B Interv Cardiol. 2021; 16:e11.
PMID: 34194543 PMC: 8239956. DOI: 10.15420/icr.2020.36.
Lawin D, Lawrenz T, Radke K, Wolff A, Stellbrink C Clin Res Cardiol. 2021; 111(2):175-185.
PMID: 33772362 DOI: 10.1007/s00392-021-01847-6.
Bytyci I, Nistri S, Morner S, Henein M J Clin Med. 2020; 9(10).
PMID: 32977442 PMC: 7598206. DOI: 10.3390/jcm9103062.
Li C, Shi Y Arq Bras Cardiol. 2019; 112(4):432-438.
PMID: 30942295 PMC: 6459438. DOI: 10.5935/abc.20190060.
Fitzgerald P, Kusumoto F J Interv Card Electrophysiol. 2018; 52(3):403-408.
PMID: 30097789 DOI: 10.1007/s10840-018-0433-0.